Literature DB >> 16565135

Ramifications of screening for breast cancer: overdiagnosis in the Malmö trial was considerably underestimated.

Peter C Gøtzsche.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16565135      PMCID： PMC1410834          DOI： 10.1136/bmj.332.7543.727-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  On the benefits and harms of screening for breast cancer.

Authors:  Peter C Gøtzsche
Journal:  Int J Epidemiol       Date:  2004-02       Impact factor: 7.196

2.  Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.

Authors:  Sophia Zackrisson; Ingvar Andersson; Lars Janzon; Jonas Manjer; Jens Peter Garne
Journal:  BMJ       Date:  2006-03-03

3.  Cochrane review on screening for breast cancer with mammography.

Authors:  O Olsen; P C Gøtzsche
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

4.  The costs and benefits of breast cancer screening.

Authors:  A B Miller
Journal:  Am J Prev Med       Date:  1993 May-Jun       Impact factor: 5.043

5.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15
  5 in total
  2 in total

Review 1.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

Review 2.  Methodologic approaches to evaluating new highly sensitive diagnostic tests: avoiding overdiagnosis.

Authors:  Joris A H de Groot; Christiana A Naaktgeboren; Johannes B Reitsma; Karel G M Moons
Journal:  CMAJ       Date:  2016-07-04       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.